Professor David Wheeler (UCL Renal Medicine) said high costs have to be assessed against the increasing problem of chronic diseases. Levels of advanced-stage chronic kidney disease are forecast to rise 60 per cent by 2032 in eight countries, including the US, China and Brazil.
Read: Financial Times (£)